SE8903625L - Antibacterial composition - Google Patents

Antibacterial composition

Info

Publication number
SE8903625L
SE8903625L SE8903625A SE8903625A SE8903625L SE 8903625 L SE8903625 L SE 8903625L SE 8903625 A SE8903625 A SE 8903625A SE 8903625 A SE8903625 A SE 8903625A SE 8903625 L SE8903625 L SE 8903625L
Authority
SE
Sweden
Prior art keywords
antibacterial composition
infections
caused
milk
milks
Prior art date
Application number
SE8903625A
Other languages
Unknown language ( )
English (en)
Other versions
SE465109B (sv
SE8903625D0 (sv
Inventor
Bengt Andersson
Catharina Svanborg Eden
Gustav Aniansson
Ragnar Lindstedt
Original Assignee
Bengt Andersson
Catharina Svanborg Eden
Gustav Aniansson
Ragnar Lindstedt
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bengt Andersson, Catharina Svanborg Eden, Gustav Aniansson, Ragnar Lindstedt filed Critical Bengt Andersson
Priority to SE8903625A priority Critical patent/SE465109B/sv
Publication of SE8903625D0 publication Critical patent/SE8903625D0/sv
Priority to DK90916537T priority patent/DK0454813T3/da
Priority to DE69032646T priority patent/DE69032646T2/de
Priority to HU912203A priority patent/HU212935B/hu
Priority to AT90916537T priority patent/ATE170754T1/de
Priority to AU66470/90A priority patent/AU633647B2/en
Priority to EP90916537A priority patent/EP0454813B1/en
Priority to ES90916537T priority patent/ES2121755T3/es
Priority to PCT/SE1990/000702 priority patent/WO1991006308A1/en
Priority to CA002044244A priority patent/CA2044244A1/en
Priority to JP2515465A priority patent/JPH04503077A/ja
Priority to KR1019910700615A priority patent/KR920700678A/ko
Publication of SE8903625L publication Critical patent/SE8903625L/sv
Priority to NO91912391A priority patent/NO912391L/no
Priority to SU914895868A priority patent/RU2035913C1/ru
Priority to FI913154A priority patent/FI102516B1/sv
Publication of SE465109B publication Critical patent/SE465109B/sv
Priority to US08/880,132 priority patent/US5968901A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
    • A23J1/00—Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites
    • A23J1/20—Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites from milk, e.g. casein; from whey
    • A23J1/202—Casein or caseinates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4732—Casein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Food Science & Technology (AREA)
  • Pulmonology (AREA)
  • Polymers & Plastics (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
SE8903625A 1989-10-30 1989-10-30 Antibakteriell komposition SE465109B (sv)

Priority Applications (16)

Application Number Priority Date Filing Date Title
SE8903625A SE465109B (sv) 1989-10-30 1989-10-30 Antibakteriell komposition
KR1019910700615A KR920700678A (ko) 1989-10-30 1990-10-30 항-박테리아 성분물
PCT/SE1990/000702 WO1991006308A1 (en) 1989-10-30 1990-10-30 A casein fraction for therapeutic, profylactic and/or diagnostic use in infections of the respiratory tract
JP2515465A JPH04503077A (ja) 1989-10-30 1990-10-30 抗菌組成物
HU912203A HU212935B (en) 1989-10-30 1990-10-30 Process for producing pharmaceutical compositions, medicinal human aliments and animal food containing casein
AT90916537T ATE170754T1 (de) 1989-10-30 1990-10-30 Eine caseinfraktion zur therapeutischen vorbeugenden und/oder diagnostischen verwendung bei atemweginfektionen
AU66470/90A AU633647B2 (en) 1989-10-30 1990-10-30 A casein fraction for therapeutic, profylactic and/or diagnostic use in infections of the respiratory tract
EP90916537A EP0454813B1 (en) 1989-10-30 1990-10-30 A casein fraction for therapeutic, prophylactic and/or diagnostic use in infections of the respiratory tract
ES90916537T ES2121755T3 (es) 1989-10-30 1990-10-30 Fraccion de caseina para uso terapeutico, profilactico y/o diagnostico en infecciones del tracto respiratorio.
DK90916537T DK0454813T3 (da) 1989-10-30 1990-10-30 Caseinfraktion til terapeutisk, profylaktisk og/eller diagnostisk anvendelse ved infektioner i åndedrætssystemet
CA002044244A CA2044244A1 (en) 1989-10-30 1990-10-30 Antibacterial composition
DE69032646T DE69032646T2 (de) 1989-10-30 1990-10-30 Eine caseinfraktion zur therapeutischen vorbeugenden und/oder diagnostischen verwendung bei atemweginfektionen
NO91912391A NO912391L (no) 1989-10-30 1991-06-19 Kaseinfraksjon for terapeutisk, profylaktisk og/eller diagnostisk anvendelse paa infeksjoner i aandedrettsorganene.
SU914895868A RU2035913C1 (ru) 1989-10-30 1991-06-28 Средство, ингибирующее связывание s.pneumoniae и/или h. influenzae, и композиция, содержащая это средство
FI913154A FI102516B1 (sv) 1989-10-30 1991-06-28 Förfarande för framställning av en kaseinfraktion med adhesionsinhiberande verkan på bakterier
US08/880,132 US5968901A (en) 1989-10-30 1997-06-20 Antibacterial composition

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8903625A SE465109B (sv) 1989-10-30 1989-10-30 Antibakteriell komposition

Publications (3)

Publication Number Publication Date
SE8903625D0 SE8903625D0 (sv) 1989-10-30
SE8903625L true SE8903625L (sv) 1991-05-01
SE465109B SE465109B (sv) 1991-07-29

Family

ID=20377332

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8903625A SE465109B (sv) 1989-10-30 1989-10-30 Antibakteriell komposition

Country Status (15)

Country Link
EP (1) EP0454813B1 (sv)
JP (1) JPH04503077A (sv)
KR (1) KR920700678A (sv)
AT (1) ATE170754T1 (sv)
AU (1) AU633647B2 (sv)
CA (1) CA2044244A1 (sv)
DE (1) DE69032646T2 (sv)
DK (1) DK0454813T3 (sv)
ES (1) ES2121755T3 (sv)
FI (1) FI102516B1 (sv)
HU (1) HU212935B (sv)
NO (1) NO912391L (sv)
RU (1) RU2035913C1 (sv)
SE (1) SE465109B (sv)
WO (1) WO1991006308A1 (sv)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5506209A (en) * 1994-05-26 1996-04-09 Abbott Laboratories Product for inhibition of infection of mammalian cells by respiratory syncytial virus
US5643880A (en) * 1994-05-26 1997-07-01 Abbott Laboratories Product for inhibition of attachment of H. influenzae to human cells
US5538952A (en) * 1994-05-26 1996-07-23 Abbott Laboratories Inhibition of infection of mammalian cells by respiratory syncytial virus
US5707968A (en) * 1994-05-26 1998-01-13 Abbott Laboratories Inhibition of attachment of H.influenzae to human cells
WO1995032728A1 (en) * 1994-05-26 1995-12-07 Abbott Laboratories Inhibition of attachment of h. influenzae to human cells
EP0760674A1 (en) * 1994-05-26 1997-03-12 Abbott Laboratories Inhibition of infection of mammalian cells by respiratory syncytial virus
US5942254A (en) * 1995-02-27 1999-08-24 Abbott Laboratories Phosphorylated recombinant human β-casein expressed in a bacterial system
EP0862450A2 (en) * 1995-11-06 1998-09-09 Abbott Laboratories A method for inhibiting attachment of h. influenzae to human cells using phosphorylated recombinant human beta-casein
DE69629487D1 (de) * 1995-11-06 2003-09-18 Abbott Lab Phosphoryliertes rekombinantes menschliches beta-kasein für die hemmung der anheftung von h. influenzae an menschlichen zellen
AUPP494798A0 (en) 1998-07-29 1998-08-20 Pacific Biolink Pty Limited Protective protein formulation
EP1567117B1 (en) 2002-11-26 2012-02-08 The University of Chicago Prevention and treatment of microbe-mediated epithelial disorders
WO2009009156A2 (en) * 2007-07-06 2009-01-15 Laclede, Inc. Use of hydrolytic and oxidative enzymes to dissolve biofilm in airway passages

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1496671A (en) * 1975-03-27 1977-12-30 Grindstedvaerket As Anti-cancer-active sour milk fraction
FR2491334A1 (fr) * 1980-10-03 1982-04-09 Inst Nat Sante Rech Med Nouvelles substances biologiquement actives, leur obtention a partir de caseine humaine et compositions les contenant
FR2592769B1 (fr) * 1986-01-10 1990-10-12 Agronomique Inst Nat Rech Procede d'obtention d'une matiere enrichie en caseine beta, appareillage pour la mise en oeuvre de ce procede, et application des produits obtenus par ce procede comme aliments, complements alimentaires ou additifs en industrie alimentaire et pharmaceutique ou dans la preparation de peptides a activite physiologique
JP2631470B2 (ja) * 1987-05-15 1997-07-16 雪印乳業株式会社 感染防御剤

Also Published As

Publication number Publication date
CA2044244A1 (en) 1991-05-01
ES2121755T3 (es) 1998-12-16
AU6647090A (en) 1991-05-31
RU2035913C1 (ru) 1995-05-27
SE465109B (sv) 1991-07-29
NO912391D0 (no) 1991-06-19
EP0454813B1 (en) 1998-09-09
NO912391L (no) 1991-06-19
FI913154A0 (fi) 1991-06-28
FI102516B (sv) 1998-12-31
EP0454813A1 (en) 1991-11-06
AU633647B2 (en) 1993-02-04
SE8903625D0 (sv) 1989-10-30
FI102516B1 (sv) 1998-12-31
WO1991006308A1 (en) 1991-05-16
JPH04503077A (ja) 1992-06-04
DE69032646D1 (de) 1998-10-15
ATE170754T1 (de) 1998-09-15
DE69032646T2 (de) 1999-05-27
DK0454813T3 (da) 1999-02-01
KR920700678A (ko) 1992-08-10
HU212935B (en) 1996-12-30

Similar Documents

Publication Publication Date Title
SE8903625D0 (sv) Antibacterial composition
EP0909814A3 (en) Use of protein kinases for the diagnosis and treatment of Alzheimer's disease
ATE165395T1 (de) Inhibitoren des tumorwachstums aus geweben, methoden ihrer herstellung und verwendungen
AU7614196A (en) Therapeutic and diagnostic compositions
BR0214705A (pt) Composição, seu uso, método para prevenção ou tratamento de doença neurodegenerativa, e kit
EP1731166A3 (en) Streptococcus pneumoniae proteins and vaccines
BR0013814A (pt) Métodos de tratamentos de um paciente humano suscetìvel a ou diagnosticado com uma doença com anticorpos anti-erbb2, artigos industrializados, métodos de tratamentos de câncer em pacientes humanos e usos do anticorpo anti-erbb2
EP2261358A3 (en) Novel streptococcus antigen
CA2132953A1 (en) Monospecific polyclonal antibodies to shiga-like toxins
EP1757697A3 (en) Group B streptococcus antigens
MX9203629A (es) Composiciones de anticuerpos monoclonales para el tratamiento profilactico o terapeutico de infecciones bacterianas debidas a estreptococos del grupo b.
DE69628336D1 (de) Behandlung und diagnose helicobacter pylori infektionen
KR950700726A (ko) 치료 또는 진단용 조성물, 그 제조방법 및 용도(composition for therapeutic or diagnostic use, process for its preparation and its use)
WO2000058475A3 (en) Streptococcus pneumoniae antigens
ATE43500T1 (de) Herstellung von antikoerpern.
ES2136206T3 (es) Composicion antibacteriana que contiene alfalactalbumina multimerica.
WO1992021697A3 (en) Diagnostic peptides derived from m.tuberculosis antigens
DE69002946D1 (de) Paracetamol enthaltende arzneizubereitung.
WO2000015797A3 (en) Compositions and methods for the treatment of immune related diseases
Ginsburg Streptococcus.
ATE27822T1 (de) Hexapeptid, verfahren zur herstellung und pharmazeutische zusammensetzungen hieraus.
AP1638A (en) Peptide mimics of conserved gonococcal epitopes and methods and compositions using them.
Diallo et al. Neurological Complications of Typhoid Fever: Case of Guillain-Barre'Syndrome about an Observation in Dakar, Senegal
WO2002061066A8 (en) Method for producing an enzyme from a novel source
Rosembaum et al. Curative effect of oral decontamination in septicaemia from intestinal origin. Traitement de deux septicemies d'origine intestinale, par une decontamination digestive, associee a l'antibiotherapie par voie generale.

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 8903625-5

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 8903625-5

Format of ref document f/p: F